IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2022 Holdings

Filed 2022-05-16 | 11 holdings | $158.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$135.4M643,00085.2%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$22.6M1,390,79014.2%
Alkermes PLC(ALKS)SHSG01767105$369.4K14,040,0000.2%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$206.2K16,390,0000.1%
Innoviva Inc(INVA)COM45781M101$128.0K6,614,0000.1%
Gilead Sciences Inc(GILD)COM375558103$92.9K1,562,9000.1%
Amarin Corp PLCSPONS ADR NEW023111206$79.0K24,000,0000.0%
Mersana Therapeutics IncCOM59045L106$17.2K4,299,2970.0%
VOR Biopharma IncCOM929033108$4.3K707,0100.0%
Pear Therapeutics IncCLASS A COM704723105$2.5K500,3560.0%
Regulus Therapeutics IncCOM NEW75915K200$5521,851,8510.0%